RMD EBITDA Growth
ResMed · EBITDA Growth
RMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported12.66%period ending
RMD TTM EBITDA YoY % (85.71% → 12.66%)
Year-over-year change
High-resolution chart · PNG
RMD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 12.657% | |
| 25.2025% | |
| 20.4284% | |
| 21.4356% | |
| 24.9071% | |
| 15.4376% | |
| 20.7191% | |
| 19.58% | |
| 14.4465% | |
| 17.5023% | |
| 17.4482% | |
| 16.5962% | |
| 14.3664% | |
| 9.7303% | |
| 4.5436% | |
| 2.2628% | |
| 6.3112% | |
| 8.7582% | |
| 8.3776% | |
| 11.605% | |
| 12.9097% | |
| 25.3384% | |
| 34.6521% | |
| 35.1009% | |
| 35.5019% | |
| 13.9371% | |
| 8.5013% | |
| 7.1881% | |
| 6.3494% | |
| 17.2096% | |
| 19.8623% | |
| 26.0368% | |
| 24.4704% | |
| 20.0672% | |
| 18.2891% | |
| 6.7897% | |
| 4.5491% | |
| 9.0432% | |
| 5.1815% | |
| 13.4777% | |
| 12.7944% | |
| -0.4453% | |
| -0.1728% | |
| -8.3609% | |
| -9.2505% | |
| -1.2295% | |
| -0.5874% | |
| 4.8957% | |
| 8.701% | |
| 4.5721% | |
| 8.0498% | |
| 10.4587% | |
| 11.433% | |
| 36.0725% | |
| 35.931% | |
| 30.8678% | |
| 24.8988% | |
| 5.9629% | |
| 2.7839% | |
| 5.8523% | |
| 11.7889% | |
| 12.5875% | |
| 21.9207% | |
| 26.0465% | |
| 28.5763% | |
| 40.3041% | |
| 27.0877% | |
| 21.4029% | |
| 14.6485% | |
| 4.2458% | |
| 53.4289% | |
| 61.0829% | |
| 77.254% | |
| 75.7159% | |
| -14.2008% | |
| -21.1598% | |
| -29.2022% | |
| -24.6958% | |
| 6.0655% | |
| 13.7908% | |
| 19.2295% | |
| 20.2427% | |
| 34.0568% | |
| 43.9462% | |
| 52.3538% | |
| 54.4767% | |
| 41.3945% | |
| 24.1154% | |
| 12.5691% | |
| 377.1658% | |
| 331.1574% | |
| 310.9033% | |
| 295.4673% | |
| -152.297% | |
| -160.4762% | |
| -171.74% | |
| -184.3374% | |
| 15.9094% | |
| 33.2854% | |
| 27.6563% |